Dermalix

Dermalix is a bioactive, three-dimensional collagen-laminin porous-structured dermal matrix designed for advanced wound healing. It is impregnated with resveratrol-loaded microparticles composed of hyaluronic acid and dipalmitoylphosphatidylcholine (DPPC). Developed by the Ege University School of Pharmacy, it is categorized as a Class III medical device. Dermalix promotes healing by providing a structural scaffold for tissue regeneration while simultaneously delivering resveratrol to enhance angiogenesis, neovascularization, and collagen remodeling. It has demonstrated clinical efficacy in reducing oxidative stress and pro-inflammatory markers such as TNF-alpha and caspase-3, leading to significantly faster wound closure in patients with Wagner grade 1 and 2 diabetic foot ulcers. Additionally, experimental studies have explored its potential in preventing anastomotic leakage in colon surgery by improving mechanical burst pressure and neovascularization at the surgical site.

Brand names

Dermalix

Other names

Dx